These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16153225)

  • 1. Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension.
    Kurahashi T; Muramaki M; Yamanaka K; Hara I; Miyake H
    BJU Int; 2005 Oct; 96(6):895-9. PubMed ID: 16153225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of clusterin in prostate cancer correlates with Gleason score but not with prognosis in patients undergoing radical prostatectomy without neoadjuvant hormonal therapy.
    Miyake H; Muramaki M; Kurahashi T; Yamanaka K; Hara I; Gleave M; Fujisawa M
    Urology; 2006 Sep; 68(3):609-14. PubMed ID: 16979705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of the secreted form of clusterin following neoadjuvant hormonal therapy as a prognostic predictor in patients undergoing radical prostatectomy for prostate cancer.
    Miyake H; Yamanaka K; Muramaki M; Kurahashi T; Gleave M; Hara I
    Oncol Rep; 2005 Nov; 14(5):1371-5. PubMed ID: 16211311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
    Harada K; Miyake H; Kusuda Y; Fujisawa M
    BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of potential molecular markers in renal cell carcinoma: impact on clinicopathological outcomes in patients undergoing radical nephrectomy.
    Sakai I; Miyake H; Takenaka A; Fujisawa M
    BJU Int; 2009 Oct; 104(7):942-6. PubMed ID: 19388989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Aurora-A expression in renal cell carcinoma.
    Kurahashi T; Miyake H; Hara I; Fujisawa M
    Urol Oncol; 2007; 25(2):128-33. PubMed ID: 17349527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.
    Mizutani Y; Nakanishi H; Li YN; Matsubara H; Yamamoto K; Sato N; Shiraishi T; Nakamura T; Mikami K; Okihara K; Takaha N; Ukimura O; Kawauchi A; Nonomura N; Bonavida B; Miki T
    Int J Oncol; 2007 Apr; 30(4):919-25. PubMed ID: 17332931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma.
    Yildiz E; Gokce G; Kilicarslan H; Ayan S; Goze OF; Gultekin EY
    BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.
    Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH
    Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.
    Elsamman EM; Fukumori T; Tanimoto S; Nakanishi R; Takahashi M; Toida K; Kanayama HO
    BJU Int; 2006 Sep; 98(3):668-73. PubMed ID: 16925770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
    Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
    Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical symptoms in localized renal cell carcinoma reflect its invasive potential: comparative study between incidentally detected and symptomatic diseases.
    Harada K; Sakai I; Ishimura T; Inoue TA; Hara I; Miyake H
    Urol Oncol; 2006; 24(3):201-6. PubMed ID: 16678049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The detection of protein expression of clusterin and Ki-67 and the status of cell apoptosis in bladder transitional cell carcinoma].
    Chen W; Xie D; Luo JH; Wang CX; Tao Y; Zheng KL; Mei H
    Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):111-4. PubMed ID: 16620672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of clusterin in human hepatocellular carcinoma.
    Kang YK; Hong SW; Lee H; Kim WH
    Hum Pathol; 2004 Nov; 35(11):1340-6. PubMed ID: 15668890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calponin h1 expression in renal tumor vessels: correlations with multiple pathological factors of renal cell carcinoma.
    Islam AH; Ehara T; Kato H; Hayama M; Kobayashi S; Igawa Y; Nishizawa O
    J Urol; 2004 Mar; 171(3):1319-23. PubMed ID: 14767341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.
    Lidgren A; Hedberg Y; Grankvist K; Rasmuson T; Bergh A; Ljungberg B
    Eur Urol; 2006 Dec; 50(6):1272-7. PubMed ID: 16814458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of response to combined immunotherapy with interferon-alpha and low-dose interleukin-2 in metastatic renal cell carcinoma: expression patterns of potential molecular markers in radical nephrectomy specimens.
    Miyake H; Sakai I; Muramaki M; Kurahashi T; Takenaka A; Fujisawa M
    Int J Urol; 2009 May; 16(5):465-71. PubMed ID: 19467119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of major heat shock proteins in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy.
    Kurahashi T; Miyake H; Hara I; Fujisawa M
    J Urol; 2007 Feb; 177(2):757-61. PubMed ID: 17222676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High nuclear Livin expression is a favourable prognostic indicator in renal cell carcinoma.
    Haferkamp A; Bedke J; Vetter C; Pritsch M; Wagener N; Buse S; Crnkovic-Mertens I; Hoppe-Seyler K; Macher-Goeppinger S; Hoppe-Seyler F; Autschbach F; Hohenfellner M
    BJU Int; 2008 Dec; 102(11):1700-6. PubMed ID: 18990137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
    Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.